谷野裕一

タニノヒロカズ | Tanino Hirokazu

所属機関・部署：
職名：准教授
ホームページURL (1件)： https://breastlife2020.com

研究分野 (1件)：腫瘍診断、治療学

研究キーワード (6件)： TearExo , BRCAness , PDX , ヌードマウス可移植乳癌株 , エクソソーム , トリプルネガティブ乳がん

競争的資金等の研究課題 (5件)：

論文 (40件)：

Sachiko Mizumoto, Sachiko Inubushi, Mayuko Miki, Haruna Nakamura, Motoi Baba, Yuji Yamashita, Mayuko Yamamoto, Shotaro Inoue, Hirokazu Tanino, Tomonari Kunihisa. Target-Oriented Classification of Triple-negative Breast Cancer. Anticancer research. 2023. 43. 11. 5067-5072
Chihiro Wakayama, Sachiko Inubushi, Tomonari Kunihisa, Sachiko Mizumoto, Motoi Baba, Hirokazu Tanino, Ik Sung Cho, Tooru Ooya. Protein corona formation on epigallocatechin gallate-Au nanoparticles suppressed tumor accumulation. JCIS Open. 2023. 9
Sachiko Inubushi, Tomonari Kunihisa, Sachiko Mizumoto, Shotaro Inoue, Mayuko Miki, Atsushi Suetsugu, Hirokazu Tanino, Robert M Hoffman. Methionine Restriction Increases Exosome Production and Secretion in Breast Cancer Cells. Cancer genomics & proteomics. 2023. 20. 5. 412-416
Mayuko Yamamoto, Tomonari Kunihisa, Motoi Baba, Sachiko Mizumoto, Yuji Yamashita, Mayuko Miki, Sachiko Inubushi, Aoi Okamoto, Ryuhei Fujimoto, Hirokazu Tanino. A Rare Case of Bilateral Pectoralis Major Muscle Defect and Abnormal Muscle. Case Reports in Oncology. 2022. 351-355
Aoi Okamoto, Yohei Funakoshi, Masahiro Oe, Ryo Takai, Hirotaka Suto, Yoshiaki Nagatani, Meiko Nishimura, Yoshinori Imamura, Tomonari Kunihisa, Naomi Kiyota, et al. Identification of Breast Cancer Stem Cells Using a Newly Developed Long-acting Fluorescence Probe, C5S-A, Targeting ALDH1A1. Anticancer research. 2022. 42. 3. 1199-1205

MISC (14件)：

Sachiko Inubushi, Hiroki Kawaguchi, Sachiko Mizumoto, Tomonari Kunihisa, Motoi Baba, Yukiya Kitayama, Toshifumi Takeuchi, Robert M. Hoffman, Hirokazu Tanino, Ryohei Sasaki. Oncogenic miRNAs Identified in Tear Exosomes From Metastatic Breast Cancer Patients (vol 40, pg 3091, 2020). ANTICANCER RESEARCH. 2020. 40. 8. 4805-4805
Yoshimasa Kosaka, Naoko Minatani, Yoko Tanaka, Akiko Shida, Mariko Kikuchi, Hiroshi Nishimiya, Mina Waraya, Hiroshi Katoh, Takeo Sato, Norihiko Sengoku, et al. Lymph node metastasis and high serum CEA are important prognostic factors in hormone receptor positive and HER2 negative breast cancer. Molecular and clinical oncology. 2018. 9. 5. 566-574
小坂愉賢, 菊池真理子, 信太昭子, 岡本光祈子, 田中蓉子, 加藤弘, 梶田咲美乃, 谷野裕一, 山本豊, 明石定子, et al. 「それぞれの癌」難治性癌に対する治療戦略乳腺トリプルネガティブ乳癌の治療成績と今後の治療戦略. 日本癌治療学会学術集会抄録集. 2017. 55回. WS13-5
信太昭子, 小坂愉賢, 藁谷美奈, 田中蓉子, 菊池真理子, 南谷菜穂子, 加藤弘, 仙石紀彦, 谷野裕一, 渡邊昌彦. 第30回北里腫瘍フォーラム新規タキサン系抗悪性腫瘍薬による発疹に関する検討. 北里医学 = Kitasato medicine. 2016. 46. 2. 123-127
加藤弘, 谷野裕一, 渡邊昌彦. Paucicellular variant甲状腺未分化癌の経験. 日本内分泌・甲状腺外科学会雑誌. 2016. 33. Suppl.2. S261-S261

講演・口頭発表等 (10件)：

Risk analysis for chemotherapy induced nausea and vomiting (CINV) in patients receiving FEC100 treatment
(SAN ANTONIO BREAST CANCER SYMPOSIUM 43rd Annual SABCS 2018)
Phase 3 trial of carboplatin in triple negative breast cancer (TNBC) patients with residual invasive carcinoma after neoadjuvant chemotherapy (JONIE4:J-CAT trial)
(SAN ANTONIO BREAST CANCER SYMPOSIUM 43rd Annual SABCS 2018)
BRCAness as a prognostic marker in triple-negative breast cancer patients treated with neoadjuvant chemotherapy: A multicenter retrospective study
(SAN ANTONIO BREAST CANCER SYMPOSIUM 43rd Annual SABCS 2018)
オラパリブの乳癌適応拡大に向けた当院の取り組み
(日本人類遺伝学会第63回大会 2018)
乳癌切除標本における比誘電率計測と非侵襲マイクロ波散乱場断層イメージングに関する研究
(第26回日本乳癌学会学術総会 2018)

学歴 (1件)：

学位 (1件)：

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

谷野 裕一